Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EIDX

Eidos Therapeutics (EIDX)

Eidos Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EIDX
DateTimeSourceHeadlineSymbolCompany
02/05/20213:32PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:EIDXEidos Therapeutics Inc
01/28/20215:05AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EIDXEidos Therapeutics Inc
01/26/20213:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
01/26/20218:01AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EIDXEidos Therapeutics Inc
01/26/20217:48AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:EIDXEidos Therapeutics Inc
01/26/20217:47AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIDXEidos Therapeutics Inc
01/26/20217:30AMGlobeNewswire Inc.BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc.NASDAQ:EIDXEidos Therapeutics Inc
01/20/20213:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIDXEidos Therapeutics Inc
01/19/20213:01PMGlobeNewswire Inc.Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Thera...NASDAQ:EIDXEidos Therapeutics Inc
01/15/20213:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
01/13/20213:50PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
01/13/20213:30PMGlobeNewswire Inc.BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce January 21, 2021 Election Deadline for MergerNASDAQ:EIDXEidos Therapeutics Inc
01/12/20216:43AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
01/12/20216:32AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
01/12/20216:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIDXEidos Therapeutics Inc
01/07/20213:02PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
01/04/20213:31PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
01/04/20216:30AMGlobeNewswire Inc.Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Pr...NASDAQ:EIDXEidos Therapeutics Inc
12/29/20206:31AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
12/28/20203:31PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
12/15/20208:31AMEdgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:EIDXEidos Therapeutics Inc
12/04/20204:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
11/13/20204:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
11/10/20203:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
11/05/20206:30AMGlobeNewswire Inc.BridgeBio Pharma, Inc. Reports Third Quarter 2020 Financial Results And Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
11/02/20203:02PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
10/30/20203:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
10/29/20203:48PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EIDXEidos Therapeutics Inc
10/29/20203:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIDXEidos Therapeutics Inc
10/29/20203:30PMGlobeNewswire Inc.Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:EIDX